XP-005
/ Shanghai Xinpu BioTech
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
May 20, 2025
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
(clinicaltrials.gov)
- P1 | N=60 | Recruiting | Sponsor: Shanghai Jiao Tong University School of Medicine
New P1 trial • Acute Myelogenous Leukemia • Hematological Malignancies • Leukemia • Oncology
1 to 1
Of
1
Go to page
1